"Hemangioblastoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benign tumor of the nervous system that may occur sporadically or in association with VON HIPPEL-LINDAU DISEASE. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2)
Descriptor ID |
D018325
|
MeSH Number(s) |
C04.557.645.375.380.370
|
Concept/Terms |
Multiple Hemangioblastomas- Multiple Hemangioblastomas
- Hemangioblastoma, Multiple
- Hemangioblastomas, Multiple
- Multiple Hemangioblastoma
|
Below are MeSH descriptors whose meaning is more general than "Hemangioblastoma".
Below are MeSH descriptors whose meaning is more specific than "Hemangioblastoma".
This graph shows the total number of publications written about "Hemangioblastoma" by people in this website by year, and whether "Hemangioblastoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2010 | 3 | 0 | 3 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2018 | 2 | 0 | 2 |
2019 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemangioblastoma" by people in Profiles.
-
Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2024 Oct; 25(10):1325-1336.
-
Oral Hypoxia-Inducible Factor 2a Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study. Ophthalmology. 2024 Nov; 131(11):1324-1332.
-
A Cerebellar Tumor-to-Tumor Metastasis in a Patient With Von Hippel-Lindau Disease. Appl Immunohistochem Mol Morphol. 2024 May-Jun 01; 32(5):244-248.
-
Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States. Orphanet J Rare Dis. 2024 Feb 16; 19(1):73.
-
Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease. Ophthalmology. 2024 May; 131(5):622-633.
-
Transvitreal Feeder Vessel Ligation and En Bloc Resection of a Retinal Capillary Hemangioblastoma. Am J Ophthalmol. 2022 05; 237:e3-e5.
-
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. N Engl J Med. 2021 11 25; 385(22):2036-2046.
-
Multimodal Imaging in the Diagnosis of Exophytic Juxtapapillary Retinal Capillary Hemangioblastoma. Am J Ophthalmol. 2021 05; 225:128-136.
-
Hemangioblastoma-like Clear Cell Stromal Tumor of the Lung: A Clinicopathologic and Immunohistochemical Study of 5 Cases. Am J Surg Pathol. 2020 06; 44(6):771-775.
-
VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects. Retina. 2019 Dec; 39(12):2243-2253.